Clinical Trial Update: Assessment In a Real World Setting of the Effect of Inhaled Steroid-based Triple Therapy Versus the Combination of Tiotropium and Olodaterol on Reducing Chronic Obstructive Pulmonary Disease (COPD) Exacerbations [AIRWISE] [Phase 4]

View source ↗

Summary

Phase 4 real-world trial comparing inhaled steroid-based triple therapy to tiotropium/olodaterol for reducing COPD exacerbations; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Inhaled steroid-based triple therapy
• Tiotropium + Olodaterol (tiotropium/olodaterol)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 4 | Status: COMPLETED | Results posted: 2021-12-09